Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GranBio successfully operates commercial-scale 2G ethanol (cellulosic ethanol) production from sugarcane straw and bagasse; advanced nanocellulose R&D; major funding for sustainable aviation fuel (SAF) scale-up with DOE backing; leading biofuel and biomaterial projects in Brazil and the US
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GranBio.